(Unsurprisingly) I welcome further studies on the origins of #SARSCoV2

Short thread with initial thoughts on two preprints released yesterday. Bottom line: Keep following the science because many more studies are needed.

1/11
2/ Critical to any understanding of the emergence of a new pathogen are studies of the earliest known and suspected cases. Identifying the first human case of a new disease is EXTREMELY difficult, if not impossible.
3/ There could be multiple spillover events from an animal reservoir or intermediate host(s) before the virus spread efficiently. These early cases would be extremely difficult to be identify…sequencing is critical.
4/ Data from multiple studies are needed — it's like detective work (and I mean this without a police reference).

For #SARSCoV2 more studies are needed to better understand the exposures of the earliest known and even earlier potential cases. eg (ie not complete list), we need:
5/ -studies that trace back wild & domestic animals sold at Wuhan markets in autumn/winter’19, testing of any remaining samples from that time period;
-serologic studies of people in Wuhan & Hubei, serologic sampling & interviews of people who worked at markets or source farms…
6/ -any sequences from the earlier cases before first documented cases or from animals sold at markets would be hugely valuable
-studies of SARS-CoV-like viruses in animals around the world
-follow up of any positive samples🌍🌎🌏from 2019
-evidence to rule out other hypotheses…
7/ The Mar’21 @WHO-China report previously reported positive environmental results from Huanan market, that there were likely many more cases in Dec’19 than recognized based on excess mortality in early-mid Jan’20, they recommended further examination of 76k ILI episodes in’19…
8/ Several studies since Mar’21 have identified animal species that were sold at Wuhan markets that are susceptible to #SARSCoV2 infection.

The Huanan market indeed played a very important role in this pandemic, but I would urge further studies continue to be needed…
9/ …to trace back animals sold there prior to the first detected cases. We need more serology in specific populations and to ensure we further study earlier suspected cases into November 2019 and possibly earlier.

Thanks to those globally who continue to work on this.
10/ SAGO is working on their first report to @WHO. We continue to need science to guide the way, collaboration and openness from experts and the space to work.

Right, lets get back to work
11/ Here are the two preprints (not yet peer-reviewed). Lots of good threads by the authors themselves—much uncertainty remains. Paper needs peer-review.

We welcome more research in this area. Science, solutions, solidarity.

zenodo.org/record/6299116

zenodo.org/record/6291628

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Maria Van Kerkhove

Maria Van Kerkhove Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @mvankerkhove

Feb 8
Short 🧵 on #omicron (filmed yesterday)

The global situation with #COVID19 is dynamic. @WHO Global COVID-19 epi situation available here who.int/publications/m…

1/5
2/5 What is #Omicron? And what about BA.2?
3/5 What is the risk of severe disease with #Omicron?
Read 5 tweets
Jan 19
Latest @WHO Weekly #COVID19 Epidemiological Update published last night (18.01.22)

Case reporting ⬆️ 20% globally in last week, w significant variation around the world.Deaths slightly increased w 45,543 people reported dead. Far far too many when tools can prevent #VaccinEquity
In last 7 days, almost 19 million cases were reported to @WHO. True number of cases is higher & this spike is causing significant burden on health systems around the world bc hospitalisations are also increasing due to #Omicron.

NB variation in % case & death change by region
With thanks to increased #COVID19 surveillance by professionals all over the world and expanded sequencing globally, sequences shared with @gisaid allow for detailed analyses of #Omicron (and all @WHO characterised VOI and VOCs) by @WHO and partners around the world.
Read 4 tweets
Dec 1, 2021
🧵Almost 3.8 million new #COVID19 cases & 47,524 deaths were reported last week

The◼️ line is reporting deaths. This should be a much steeper decline bc of available COVID-19 vaccines. But its not bc the world is not prioritising vaccination in people at risk in ALL countries
Important: Delta is dominant worldwide and needs to be controlled. What we do for Delta will benefit Omicron - no matter what we learn about this variant.

Right now, we need to continue to drive down transmission, drive up vaccination coverage in at risk populations.
A plea: Countries that have driven down transmission need to remain vigilant & keep transmission low (& no, I don’t mean with lockdowns). We mean tailored and targeted measures in all countries based on epi and capacities.

covid19.who.int
Read 4 tweets
Sep 26, 2021
A couple of misrepresentations in the @WSJ article that I’d like to address… short thread⬇️
The @WHO SAGO is NOT the next mission team to China. It is an advisory group set up to establish a framework to study the origins of emerging and re-emerging pathogens of pandemic potential when they emerge.
For decades, we have seen the repeated threat of emergence of known & new threats: SARS-CoV, MERS-CoV, avian flu, pandemic flu H1N1pdm09, Ebola, Marburg, Lassa, Nipah, Zika… SARS-CoV-2. #COVID19 was disease X and the next disease X is out there.
Read 10 tweets
Aug 31, 2021
Short 🧵 on @WHO’s latest #COVID19 Epi update (available now)

Globally, trends continue to be worrying. Plateauing at more than 4.3 million cases each week and around 67k deaths is tragic - there is no easy way to say this.

Full sit rep here
who.int/publications/m…
In our update, we provide more info at regional levels, a summary of VOC geographic distribution and info on a new global classified VOI “Mu” B.1.621.

Some basics of Mu:
➡️1st identified in Colombia in Jan 2021
➡️Has mutations that warrant further study
(keep reading)
➡️Data on Mu has been shread with @WHO Virus Evolution Working Group 🙏
➡️As of 29 Aug, 4.5k sequences of Mu have been uploaded to @GISAID from 39 countries
➡️ Circulation of Mu is ⬇️ globally & < 0.1% of currently shared sequences of Mu, but this needs careful observation
Read 4 tweets
Aug 30, 2021
Quick thread on the C.1.2 variant that has been in the news and on twitter today…

First remember that the more the virus spreads the more opportunity it has to change. We have the tools to prevent infections, reduce the spread & save lives - lets use them.

Keep reading…
@WHO has regularly been discussing with South African researchers about theirr work on sequencing throughout the #COVID19 pandemic. 🙏 We are grateful for researchers in 🇿🇦 who first presented their findings on variant C.1.2 to the WHO Virus Evolution Working Group in July ‘21.
Thanks to these scientific collaborations, sharing of sequences & analyses by 🇿🇦(eg ⬇️) & researchers around 🌍🌏🌎, @WHO & partners are able to quickly monitor & assess specific mutations and variants identified & alert the world of any potential risks. medrxiv.org/content/10.110…
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(